[O4] Oral Presentations 4

4:00 PM - 4:10 PM JST(7:00 AM - 7:10 AM UTC)Immunology

[O4-04] Innovative mucosal adjuvant development using heat-killed Escherichia coli

*Peng Gao¹, Reiko Shinkura¹ (1. Institute for Quantitative Biosciences, The University of Tokyo (Japan))

Keywords:

mucosal vaccine,IgA,adjuvant,Influenza viruses,SARS-CoV-2

Password required to view

Log in

or